Good news for experimental concept but bad news for clinically effective therapy.
作者信息
Reimer K A, Califf R M
出版信息
Circulation. 1999 Jan 19;99(2):198-200. doi: 10.1161/01.cir.99.2.198.
PMID:9892582
Abstract
摘要
相似文献
1
Good news for experimental concept but bad news for clinically effective therapy.
Circulation. 1999 Jan 19;99(2):198-200. doi: 10.1161/01.cir.99.2.198.
2
[Current therapy of coronary heart disease. Conservative measures].[冠心病的当前治疗方法。保守措施]
Internist (Berl). 1998 Sep;39(9):1001-2.
3
Mibefradil withdrawn from the market.
Ann Pharmacother. 1998 Jul-Aug;32(7-8):841. doi: 10.1345/aph.17356.
4
Mibefradil (posicor).
Compr Ther. 1997 Nov;23(11):761-3.
5
[Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Dtsch Med Wochenschr. 1998 Apr 24;123(17):547.
6
Rhabdomyolysis due to interaction of simvastatin with mibefradil.辛伐他汀与米贝拉地尔相互作用导致的横纹肌溶解症。
Lancet. 1998 Jun 27;351(9120):1929-30. doi: 10.1016/S0140-6736(05)78613-X.
7
Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
J Clin Pharmacol. 1999 Mar;39(3):310-2.
8
Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.米贝拉地尔与β受体阻滞剂联合治疗慢性心绞痛
Clin Cardiol. 1998 Feb;21(2):129. doi: 10.1002/clc.4960210214.
9
[Progress in new cardiovascular treatment. Background discussion and interview in the Basel Roche Research Center].[心血管疾病新疗法的进展。巴塞尔罗氏研究中心的背景讨论与访谈]
Fortschr Med. 1996 Feb 10;114(4):39-40.
10
Serious interaction between mibefradil and tacrolimus.
Transplantation. 1998 Oct 27;66(8):1113-5. doi: 10.1097/00007890-199810270-00026.
引用本文的文献
1
Glutathionylation of the L-type Ca2+ channel in oxidative stress-induced pathology of the heart.氧化应激诱导的心脏病理过程中L型钙离子通道的谷胱甘肽化修饰
Int J Mol Sci. 2014 Oct 22;15(10):19203-25. doi: 10.3390/ijms151019203.
Zotero 插件